|
1
|
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel.
|
J Allergy Clin Immunol
|
2010
|
5.55
|
|
2
|
Activation of airway epithelial cells by toll-like receptor agonists.
|
Am J Respir Cell Mol Biol
|
2004
|
3.16
|
|
3
|
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report.
|
J Allergy Clin Immunol
|
2010
|
2.98
|
|
4
|
Cytokine modulation of atopic dermatitis filaggrin skin expression.
|
J Allergy Clin Immunol
|
2007
|
2.79
|
|
5
|
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.
|
J Allergy Clin Immunol
|
2003
|
2.31
|
|
6
|
Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum.
|
J Allergy Clin Immunol
|
2009
|
2.20
|
|
7
|
Differential diagnosis of chronic urticaria.
|
Ann Allergy Asthma Immunol
|
2008
|
2.10
|
|
8
|
Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
|
Arch Dermatol
|
2008
|
1.85
|
|
9
|
Tight junction defects in patients with atopic dermatitis.
|
J Allergy Clin Immunol
|
2010
|
1.77
|
|
10
|
Chemokines: key players in innate and adaptive immunity.
|
J Invest Dermatol
|
2005
|
1.55
|
|
11
|
Atopic dermatitis: a disease caused by innate immune defects?
|
J Invest Dermatol
|
2009
|
1.48
|
|
12
|
Skin barrier disruption: a requirement for allergen sensitization?
|
J Invest Dermatol
|
2012
|
1.40
|
|
13
|
Cytokine modulation of atopic dermatitis filaggrin skin expression.
|
J Allergy Clin Immunol
|
2009
|
1.38
|
|
14
|
Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum.
|
J Allergy Clin Immunol
|
2010
|
1.38
|
|
15
|
IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.
|
J Allergy Clin Immunol
|
2007
|
1.38
|
|
16
|
Atopic dermatitis and asthma: parallels in the evolution of treatment.
|
Pediatrics
|
2003
|
1.30
|
|
17
|
Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-γ response.
|
J Allergy Clin Immunol
|
2011
|
1.19
|
|
18
|
The cutaneous innate immune response in patients with atopic dermatitis.
|
J Allergy Clin Immunol
|
2013
|
1.18
|
|
19
|
Innate immune defects in atopic dermatitis.
|
J Allergy Clin Immunol
|
2006
|
1.15
|
|
20
|
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report.
|
Nutr Res
|
2011
|
1.14
|
|
21
|
Filaggrin expression in oral, nasal, and esophageal mucosa.
|
J Invest Dermatol
|
2008
|
1.12
|
|
22
|
Polyinosinic:polycytidylic acid induces protein kinase D-dependent disassembly of apical junctions and barrier dysfunction in airway epithelial cells.
|
J Allergy Clin Immunol
|
2011
|
1.10
|
|
23
|
Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair.
|
J Invest Dermatol
|
2012
|
1.08
|
|
24
|
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis.
|
J Allergy Clin Immunol
|
2011
|
1.01
|
|
25
|
Keratinocytes in atopic dermatitis: inflammatory signals.
|
Curr Allergy Asthma Rep
|
2004
|
1.00
|
|
26
|
Polymorphisms in the novel gene acyloxyacyl hydroxylase (AOAH) are associated with asthma and associated phenotypes.
|
J Allergy Clin Immunol
|
2006
|
0.94
|
|
27
|
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report.
|
Nutrition
|
2011
|
0.92
|
|
28
|
Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis.
|
J Invest Dermatol
|
2011
|
0.88
|
|
29
|
The effect of low-magnitude whole body vibration on bone density and microstructure in men and women with chronic motor complete paraplegia.
|
J Spinal Cord Med
|
2014
|
0.86
|
|
30
|
Update on systemic therapies for atopic dermatitis.
|
Curr Opin Allergy Clin Immunol
|
2012
|
0.85
|
|
31
|
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report.
|
J Am Acad Dermatol
|
2011
|
0.85
|
|
32
|
Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum.
|
J Invest Dermatol
|
2011
|
0.84
|
|
33
|
Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine.
|
Arch Dermatol
|
2006
|
0.84
|
|
34
|
Body composition of women and men with complete motor paraplegia.
|
J Spinal Cord Med
|
2013
|
0.83
|
|
35
|
Fibroblast growth factor-peptide improves barrier function and proliferation in human keratinocytes after radiation.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.83
|
|
36
|
Quantification of quantum dot murine skin penetration with UVR barrier impairment.
|
Nanotoxicology
|
2013
|
0.83
|
|
37
|
Sustained protein kinase D activation mediates respiratory syncytial virus-induced airway barrier disruption.
|
J Virol
|
2013
|
0.83
|
|
38
|
Weight bearing through lower limbs in a standing frame with and without arm support and low-magnitude whole-body vibration in men and women with complete motor paraplegia.
|
Am J Phys Med Rehabil
|
2012
|
0.82
|
|
39
|
The signal transducer and activator of transcription 6 gene (STAT6) increases the propensity of patients with atopic dermatitis toward disseminated viral skin infections.
|
J Allergy Clin Immunol
|
2011
|
0.81
|
|
40
|
Pathophysiology of chronic urticaria.
|
Ann Allergy Asthma Immunol
|
2008
|
0.80
|
|
41
|
Mannan-binding lectin levels and activity are not altered in atopic dermatitis patients with a history of eczema herpeticum.
|
Dermatol Res Pract
|
2011
|
0.78
|
|
42
|
Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines.
|
Clin Immunol
|
2006
|
0.78
|
|
43
|
Cutaneous myiasis arising in an eccrine adnexal neoplasm.
|
Dermatol Online J
|
2008
|
0.76
|
|
44
|
IL-17: important for host defense, autoimmunity, and allergy?
|
J Invest Dermatol
|
2010
|
0.76
|
|
45
|
Evaluation of the effect of the specific CCR1 antagonist CP-481715 on the clinical and cellular responses observed following epicutaneous nickel challenge in human subjects.
|
Contact Dermatitis
|
2008
|
0.76
|
|
46
|
Wanted: A study with omalizumab to determine the role of IgE-mediated pathways in atopic dermatitis.
|
J Am Acad Dermatol
|
2006
|
0.76
|
|
47
|
What is eotaxin doing in the pleura? Insights into innate immunity from pleural mesothelial cells.
|
Am J Respir Cell Mol Biol
|
2002
|
0.75
|
|
48
|
Addendum guidelines for the prevention of peanut allergy in the United States.
|
JAAPA
|
2017
|
0.75
|
|
49
|
Addendum Guidelines for the Prevention of Peanut Allergy in the United States: Summary of the National Institute of Allergy and Infectious Diseases-Sponsored Expert Panel.
|
J Acad Nutr Diet
|
2017
|
0.75
|
|
50
|
The effect of etanercept on the human cutaneous allergic response.
|
J Allergy Clin Immunol
|
2008
|
0.75
|
|
51
|
Emerging therapeutic options for atopic dermatitis: beyond TIMs.
|
Curr Allergy Asthma Rep
|
2006
|
0.75
|